Molina Healthcare (MOH) is trading higher after reporting first-quarter 2026 results that beat on adjusted earnings and reaffirmed its full-year outlook. The company reported adjusted EPS of $2.35 and reiterated 2026 adjusted EPS guidance of at least $5.00, helping support the shares after investors had discounted the name heavily following earlier profitability concerns. (markets.financialcontent.com)

For Q1 2026, Molina reported total revenue of about $10.8B and premium revenue of about $10.2B, with GAAP EPS of $0.27 and adjusted EPS of $2.35. The company also disclosed a medical care ratio of 91.1% for the quarter, a key profitability driver for managed-care names. (markets.financialcontent.com)

The earnings beat and reaffirmed guide are landing at a sensitive moment for MOH, which has been trying to rebuild credibility after a sharp guidance reset earlier in 2026 tied to higher medical costs. With the Q1 report and the April 23, 2026 earnings call providing fresh detail on utilization trends and cost controls, today’s move reflects relief that results are tracking near—or modestly ahead of—current expectations and that management did not cut the 2026 floor again. (investors.molinahealthcare.com)

Investors will be listening for specifics from management on how medical costs are trending into the rest of 2026, whether state Medicaid rate actions are keeping pace with utilization, and how the company plans to deliver on the at-least $5.00 adjusted EPS target despite lower year-over-year earnings. Any changes to membership expectations, contract performance, or segment-level margin commentary could determine whether the post-earnings rally extends or fades. (markets.financialcontent.com)